A.R.T. Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

A.R.T. Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,142	Closed	-$423K	–	1936
2019 Q3	$423K	Sell	10,142 -46,000	-82%	-$1.94M	0.02%	921
2019 Q2	$2.46M	Buy	56,142 +25,600	+84%	+$1.44M	0.14%	191
2019 Q1	$1.57M	Buy	+30,542	New	+$1.32M	0.09%	325
2018 Q4	–	Sell	-42,838	Closed	-$1.61M	–	1907
2018 Q3	$1.61M	Buy	+42,838	New	+$1.58M	0.07%	370
2018 Q2	–	Sell	-46,738	Closed	-$1.2M	–	2014
2018 Q1	$1.2M	Buy	+46,738	New	+$1.4M	0.05%	579

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

A.R.T. Advisors's BHVN Position: Q4 2019 in Review

A.R.T. Advisors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2019, closing a stake of 10,142 shares — an estimated $423K sold.

A.R.T. Advisors first reported a position in BHVN in Q1 2018 and held it in 5 quarters. The position peaked at $2.46M in Q2 2019. 188 funds tracked by Wall St. Rank hold BHVN as of Q4 2019.

A.R.T. Advisors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 10,142 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2019, an estimated $423K.
A.R.T. Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 5 quarters.
A.R.T. Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.46M in Q2 2019.
188 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.